Aligos Therapeutics Inc. (ALGS)
NASDAQ: ALGS
· Real-Time Price · USD
8.10
0.39 (5.06%)
At close: Jun 16, 2025, 3:59 PM
8.25
1.91%
After-hours: Jun 16, 2025, 06:36 PM EDT
5.06% (1D)
| Bid | 7.7 |
| Market Cap | 49.5M |
| Revenue (ttm) | 3.27M |
| Net Income (ttm) | -53.26M |
| EPS (ttm) | -17.47 |
| PE Ratio (ttm) | -0.46 |
| Forward PE | -0.89 |
| Analyst | Buy |
| Ask | 9 |
| Volume | 59,479 |
| Avg. Volume (20D) | 159,276 |
| Open | 7.90 |
| Previous Close | 7.71 |
| Day's Range | 7.78 - 8.28 |
| 52-Week Range | 3.76 - 46.80 |
| Beta | 2.69 |
About ALGS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ALGS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ALGS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-19.55%
Aligos Therapeutics shares are trading lower after...
Unlock content with
Pro Subscription
4 months ago
-19.25%
Aligos Therapeutics shares are trading lower after the company announced a $105 million private placement financing round.
